These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1030 related articles for article (PubMed ID: 29217002)
1. The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease. Chieffo A; Tanaka A; Giustino G; Briede I; Sawaya FJ; Daemen J; Kawamoto H; Meliga E; D'Ascenzo F; Cerrato E; Stefanini GG; Capodanno D; Mangiameli A; Templin C; Erglis A; Morice MC; Mehran R; Van Mieghem NM; Nakamura S; De Benedictis M; Pavani M; Varbella F; Pisaniello M; Sharma SK; Tamburino C; Tchetche D; Colombo A; JACC Cardiovasc Interv; 2017 Dec; 10(23):2401-2410. PubMed ID: 29217002 [TBL] [Abstract][Full Text] [Related]
2. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114 [TBL] [Abstract][Full Text] [Related]
3. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A JACC Cardiovasc Interv; 2014 Apr; 7(4):354-61. PubMed ID: 24630886 [TBL] [Abstract][Full Text] [Related]
4. Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. Chieffo A; Meliga E; Latib A; Park SJ; Onuma Y; Capranzano P; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Kim YH; Buszman PE; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capodanno D; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A JACC Cardiovasc Interv; 2012 Jul; 5(7):718-27. PubMed ID: 22814776 [TBL] [Abstract][Full Text] [Related]
5. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery]. Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341 [No Abstract] [Full Text] [Related]
6. Second vs. First generation drug eluting stents in multiple vessel disease and left main stenosis: Two-year follow-up of the observational, prospective, controlled, and multicenter ERACI IV registry. Haiek C; Fernández-Pereira C; Santaera O; Mieres J; Rifourcat I; Lloberas J; Larribau M; Pocoví A; Rodriguez-Granillo AM; Sarmiento RA; Antoniucci D; Rodriguez AE Catheter Cardiovasc Interv; 2017 Jan; 89(1):37-46. PubMed ID: 26947138 [TBL] [Abstract][Full Text] [Related]
7. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience. Chieffo A; Magni V; Latib A; Maisano F; Ielasi A; Montorfano M; Carlino M; Godino C; Ferraro M; Calori G; Alfieri O; Colombo A JACC Cardiovasc Interv; 2010 Jun; 3(6):595-601. PubMed ID: 20630452 [TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of percutaneous coronary interventions or coronary artery bypass grafting for left main coronary artery disease in octogenarians (from a Drug-Eluting stent for LefT main Artery registry substudy). Conrotto F; Scacciatella P; D'Ascenzo F; Chieffo A; Latib A; Park SJ; Kim YH; Onuma Y; Capranzano P; Jegere S; Makkar R; Palacios I; Buszman P; Chakravarty T; Mehran R; Naber C; Margey R; Leon M; Moses J; Fajadet J; Lefèvre T; Morice MC; Erglis A; Tamburino C; Alfieri O; D'Amico M; Marra S; Serruys PW; Colombo A; Meliga E Am J Cardiol; 2014 Jun; 113(12):2007-12. PubMed ID: 24793677 [TBL] [Abstract][Full Text] [Related]
9. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data. Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199 [TBL] [Abstract][Full Text] [Related]
10. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease. Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A; JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416 [TBL] [Abstract][Full Text] [Related]
11. Comparative long-term efficacy and safety of drug-eluting stent versus coronary artery bypass grafting in ostial left main coronary artery disease: analysis of the MAIN-COMPARE registry. Lee SW; Kim SH; Kim SO; Han S; Kim YH; Park DW; Kang SJ; Lee CW; Park SW; Park SJ Catheter Cardiovasc Interv; 2012 Aug; 80(2):206-12. PubMed ID: 22234884 [TBL] [Abstract][Full Text] [Related]
12. Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Interventions in Patients With Unprotected Left Main Coronary Artery Disease. Zheng Z; Xu B; Zhang H; Guan C; Xian Y; Zhao Y; Fan H; Yang Y; Wang W; Gao R; Hu S JACC Cardiovasc Interv; 2016 Jun; 9(11):1102-11. PubMed ID: 27282597 [TBL] [Abstract][Full Text] [Related]
13. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry. Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K; JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178 [TBL] [Abstract][Full Text] [Related]
14. Left Main Stenting in Comparison With Surgical Revascularization: 10-Year Outcomes of the (Left Main Coronary Artery Stenting) LE MANS Trial. Buszman PE; Buszman PP; Banasiewicz-Szkróbka I; Milewski KP; Żurakowski A; Orlik B; Konkolewska M; Trela B; Janas A; Martin JL; Kiesz RS; Bochenek A JACC Cardiovasc Interv; 2016 Feb; 9(4):318-327. PubMed ID: 26892080 [TBL] [Abstract][Full Text] [Related]
15. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study. Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199 [TBL] [Abstract][Full Text] [Related]
16. Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial. Serruys PW; Cavalcante R; Collet C; Kappetein AP; Sabik JF; Banning AP; Taggart DP; Sabaté M; Pomar J; Boonstra PW; Lembo NJ; Onuma Y; Simonton CA; Morice MC; McAndrew T; Dressler O; Stone GW JACC Cardiovasc Interv; 2018 Jul; 11(13):1234-1243. PubMed ID: 29976359 [TBL] [Abstract][Full Text] [Related]
17. Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry. Capodanno D; Gargiulo G; Buccheri S; Chieffo A; Meliga E; Latib A; Park SJ; Onuma Y; Capranzano P; Valgimigli M; Narbute I; Makkar RR; Palacios IF; Kim YH; Buszman PE; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Leon MB; Moses JW; Fajadet J; Lefèvre T; Morice MC; Erglis A; Alfieri O; Serruys PW; Colombo A; Tamburino C; JACC Cardiovasc Interv; 2016 Nov; 9(22):2280-2288. PubMed ID: 27884354 [TBL] [Abstract][Full Text] [Related]
18. Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials. Cassese S; Kufner S; Xhepa E; Byrne RA; Kreutzer J; Ibrahim T; Tiroch K; Valgimigli M; Tölg R; Fusaro M; Schunkert H; Laugwitz KL; Mehilli J; Kastrati A Clin Res Cardiol; 2016 Jul; 105(7):575-84. PubMed ID: 26689707 [TBL] [Abstract][Full Text] [Related]
19. First generation versus new generation drug-eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: the Milan and New-Tokyo (MITO) registry. Naganuma T; Chieffo A; Takagi K; Panoulas VF; Mitomo S; Sticchi A; Latib A; Miyazaki T; Sato K; Costopoulos C; Fujino Y; Montorfano M; Carlino M; Nakamura S; Colombo A Catheter Cardiovasc Interv; 2015 Feb; 85(3):E63-9. PubMed ID: 25099758 [TBL] [Abstract][Full Text] [Related]
20. Comparison Between 1- and 2-Stent Strategies in Unprotected Distal Left Main Disease: The Milan and New-Tokyo Registry. Takagi K; Naganuma T; Chieffo A; Fujino Y; Latib A; Tahara S; Ishiguro H; Montorfano M; Carlino M; Kawamoto H; Kurita N; Hozawa K; Nakamura S; Nakamura S; Colombo A Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27810964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]